Edition:
India

Vectura Group PLC (VEC.L)

VEC.L on London Stock Exchange

137.50GBp
26 Aug 2016
Change (% chg)

-0.50p (-0.36%)
Prev Close
138.00p
Open
137.80p
Day's High
138.40p
Day's Low
136.00p
Volume
1,218,977
Avg. Vol
1,815,765
52-wk High
200.10p
52-wk Low
135.00p

VEC.L

Chart for VEC.L

About

Vectura Group plc is engaged in research, development and commercialization of therapeutic products and drug delivery systems for human use. The Company's products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) - LABA-LAMA; Seebri Breezhaler (EU and RoW) - LAMA; AirFluSal Forspiro (EU and RoW) -... (more)

Overall

Beta: 0.39
Market Cap(Mil.): £930.72
Shares Outstanding(Mil.): 676.89
Dividend: --
Yield (%): --

Financials

  VEC.L Industry Sector
P/E (TTM): 120.30 36.93 36.63
EPS (TTM): 0.01 -- --
ROI: 1.98 14.69 14.12
ROE: 2.18 15.48 15.04

BRIEF-Vectura initiates legal proceedings against GSK in the U.S.

* Vectura initiates legal proceedings against GlaxoSmithKline Plc (GSK)

27 Jul 2016

BRIEF-HBM Healthcare Investments: merger of Skyepharma and Vectura effective

* Recommended all share merger of Skyepharma and Vectura becomes effective

10 Jun 2016

BRIEF-Vectura FY core earnings rise 43 pct

* EBITDA(1) up 43% to £23.2m (2014/15: £16.2m) Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

26 May 2016

BRIEF-Vectura & Propeller Health announce collaboration

* Vectura and propeller health announce collaboration to develop digitally-connected inhalers to address chronic respiratory diseases Source text for Eikon: Further company coverage:

24 May 2016

BRIEF-Vectura Group says CMA not to investigate Vectura-Skyepharma merger

* CMA has confirmed that proposed recommended all share merger of Vectura and Skyepharma does not qualify for investigation

16 May 2016

BRIEF-UK's CMA says no relevant merger situation in Vectura-Skyepharma deal

* UK's CMA says decided that a relevant merger situation has not been created in anticipated acquisition by Vectura Group Plc of Skyepharma Plc Source text for Eikon:

16 May 2016

Drugmaker Vectura Group to buy SkyePharma

March 16 Drugmaker Vectura Group said on Wednesday it would buy SkyePharma Plc in an all-stock deal that would give it SkyePharma's drug delivery platform.

16 Mar 2016

BRIEF-HBM Healthcare Investments says Skyepharma to merge with Vectura group

* Under the terms of the proposed merger, Skyepharma shareholders will be entitled to receive 2.7977 new Vectura shares for every Skyepharma share

16 Mar 2016

BRIEF-Vectura Group to buy Skyepharma for 441.3 million stg

* Vectura Group and Skyepharma Plc have reached agreement on terms of a recommended merger between Vectura and Skyepharma

16 Mar 2016

Earnings vs. Estimates